|
The device was used for treatment.The device was not returned for analysis, therefore, the exact cause of the product issue cannot be determined and the clinical observation could not be confirmed.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections.However, following controls are in place to mitigate the reported product issue.Per procedure adelante-s introducer sheath in process and final inspection overmolded sheath : visual inspection: a) verify hub to be smooth, no cracks, sinking or unfilled areas, and check for fm; b) verify hub shape as per drawing.Check for excessive flash (maximum allowable limit is 0.75 mm2).C)using 10x microscope, look down into hub for irregularities.Verify smooth transition between sheath and hub on inside of hub.D) verify one of the score lines of the sheath is aligned with the break line of the hub (handle).Break and peel test: manually break the sheath and hub and verify that the seal splits easily without extreme elongation.Also verify that the split cap and seal remain secure and do not break free or loosen from the sheath hub.Strength test: using samples from break and peel test, use force gauge to determine the strength of the introducer sheath hub and side tube joint by placing the broken and peeled sheath hub and side tube in opposing pull tester clamps.Pull at a rate of 20 in/min until joint completely separates.The peak force at separation shall be > 3.37 lbf (15n).Per instructions for use (ifu) : sharply snap the tabs of valve housing in a plane perpendicular to the long axis of the sheath to split the valve and peel sheath apart while withdrawing from the vessel.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|